July 23, 2013 at 07:36 AM EDT
Cytokinetics (CYTK) Amends Protocol for BENEFIT-ALS; Patient Enrollment Expected to Conclude in 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8521974 for the full story.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here